Martine Rothblatt

Area of Focus

Martine Rothblatt works in the fields of biotechnology, electric aviation, and transhumanism, focusing on medical innovation, organ transplantation, and the future of human consciousness. Her activities span from developing life-saving pharmaceutical treatments to pioneering sustainable transport and exploring technological immortality.

Born

Martine Rothblatt was born in 1954 in Chicago, Illinois.

Citizenship

Martine Rothblatt is a citizen of the United States.

Education

Rothblatt earned J.D. and M.B.A. degrees from the University of California, Los Angeles, and a Ph.D. in medical ethics from Queen Mary University of London.

Occupations

She is the founder and chairwoman of the board of United Therapeutics, a biopharmaceutical company.

Career & Projects

Rothblatt has founded several companies, including SiriusXM Satellite Radio and United Therapeutics. Her work in biotechnology includes the development of treatments for pulmonary hypertension and research into xenotransplantation, notably the 2022 attempt to transplant a genetically modified porcine heart. She also unveiled a complex 3D-printed human lung scaffold in 2022.

In aviation, she has pioneered electric-powered helicopter flight, setting multiple world records for duration, speed, and distance. She is currently working on hydrogen-powered helicopter technology, with expectations for FAA approval by 2028, and has facilitated the delivery of transplantable organs via electric drones.

Additionally, she launched the Terasem Movement in 2004, a transhumanist organization focused on mind uploading and techno-immortality. She also developed the Unisphere, a large-scale net-zero office building, and created the Lifenaut.com platform for digital consciousness preservation.

Vision for the Future

Rothblatt aims to achieve technological immortality through mind uploading and the development of "mindclones." She advocates for the use of geoethical nanotechnology and cyberconsciousness to extend human life and experience.

She is also committed to sustainable infrastructure and medical accessibility, seeking to eliminate organ shortages through xenotransplantation and 3D-printed organ scaffolds. Her vision includes a future where transportation, particularly for medical logistics, is powered by zero-emission electric and hydrogen-based aviation technologies.